You can:
Name | Gastric inhibitory polypeptide receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | GIPR |
Synonym | GIP-R GIP receptor Glucose-dependent insulinotropic polypeptide receptor Gippr |
Disease | Type 2 diabetes |
Length | 466 |
Amino acid sequence | MTTSPILQLLLRLSLCGLLLQRAETGSKGQTAGELYQRWERYRRECQETLAAAEPPSGLACNGSFDMYVCWDYAAPNATARASCPWYLPWHHHVAAGFVLRQCGSDGQWGLWRDHTQCENPEKNEAFLDQRLILERLQVMYTVGYSLSLATLLLALLILSLFRRLHCTRNYIHINLFTSFMLRAAAILSRDRLLPRPGPYLGDQALALWNQALAACRTAQIVTQYCVGANYTWLLVEGVYLHSLLVLVGGSEEGHFRYYLLLGWGAPALFVIPWVIVRYLYENTQCWERNEVKAIWWIIRTPILMTILINFLIFIRILGILLSKLRTRQMRCRDYRLRLARSTLTLVPLLGVHEVVFAPVTEEQARGALRFAKLGFEIFLSSFQGFLVSVLYCFINKEVQSEIRRGWHHCRLRRSLGEEQRQLPERAFRALPSGSGPGEVPTSRGLSSGTLPGPGNEASRELESYC |
UniProt | P48546 |
Protein Data Bank | N/A |
GPCR-HGmod model | P48546 |
3D structure model | This predicted structure model is from GPCR-EXP P48546. |
BioLiP | N/A |
Therapeutic Target Database | T41750 |
ChEMBL | CHEMBL4383 |
IUPHAR | 248 |
DrugBank | N/A |
Name | CHEMBL2159341 |
---|---|
Molecular formula | C32H27Cl2N3O3 |
IUPAC name | 3-[[4-[(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methylnaphthalen-2-yl)pyrazol-1-yl]ethyl]benzoyl]amino]propanoic acid |
Molecular weight | 572.486 |
Hydrogen bond acceptor | 4 |
Hydrogen bond donor | 2 |
XlogP | 7.2 |
Synonyms | BDBM50393785 |
Inchi Key | KNTOEHKTBLUGLN-FQEVSTJZSA-N |
Inchi ID | InChI=1S/C32H27Cl2N3O3/c1-19-3-4-24-14-25(10-9-23(24)13-19)30-18-29(26-15-27(33)17-28(34)16-26)36-37(30)20(2)21-5-7-22(8-6-21)32(40)35-12-11-31(38)39/h3-10,13-18,20H,11-12H2,1-2H3,(H,35,40)(H,38,39)/t20-/m0/s1 |
PubChem CID | 60170856 |
ChEMBL | CHEMBL2159341 |
IUPHAR | N/A |
BindingDB | 50393785 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand is heavier than 500 daltons. This ligand has a partition coefficient log P greater than 5. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 753.0 nM | PMID22708876 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218